跳至主要内容
临床试验/NCT07133620
NCT07133620招募中不适用

The Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic Surgery

The First Affiliated Hospital of Xiamen University1 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2025年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
112
试验地点
1
主要终点
I-FEED(Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms)Score

研究概览

简要总结

The purpose of this clinical trial is to understand the effect of percutaneous acupoint electrical stimulation on postoperative gastrointestinal dysfunction. It will also investigate the safety of percutaneous acupoint electrical stimulation. The main questions that this trial aims to answer are:

Can percutaneous acupoint electrical stimulation alleviate postoperative gastrointestinal dysfunction? Through which mechanisms do they function?

Participants will:

Preoperatively, patients were either given or not given percutaneous acupoint electrical stimulation.

Record their symptoms and biological indicators within 5 days after the operation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age > 18 years
  • •BMI < 28 kg/m2
  • •ASA classification is I-III grade
  • •Laparoscopic urological procedures under general anesthesia, including but not limited to laparoscopic nephrectomy and laparoscopic radical prostatectomy for prostate cancer
  • •Normal comprehension ability, and the patient or his/her family members can cooperate in filling out the questionnaire
  • •Voluntary to sign the informed consent form

排除标准

  • •Comprehensive assessment of severe cardiovascular, pulmonary and cerebrovascular diseases (such as severe coronary heart disease, valve diseases, respiratory failure, cerebral hemorrhage, cerebral infarction, etc.)
  • •Preoperative use of analgesic and gastrointestinal motility drugs
  • •TEAS contraindications (having electronic devices in the body, skin damage or infection at the stimulation site)
  • •Previous history of TEAS or electro-acupuncture treatment
  • •Previous history of gastrointestinal surgery, long-term gastrointestinal motility disorders and severe intestinal diseases
  • •Pregnancy

研究组 & 干预措施

TEAS group

Experimental

干预措施: Transcutaneous electrical acupoint stimulation (Device)

Sham TEAS group

Sham Comparator

干预措施: Sham transcutaneous Electrical Acupoint Stimulation (Device)

结局指标

主要结局

I-FEED(Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms)Score

时间窗: Three days after the operation

The I-FEED score consists of five aspects: eating, nausea, vomiting, physical examination, and duration of symptoms. The lowest score is 0 and the highest is 14. The higher the score, the worse the result. The normal I-FEED score is 0-2 points. Postoperative gastrointestinal intolerance (POGI) is 3-5 points, and Postoperative gastrointestinal dysfunction (POGD) is ≥ 6 points.

次要结局

  • The concentrations of motilin (MTL)(postoperative 5 days)
  • Interleukin-6 (IL-6)(postoperative 5 days)
  • Acetylcholine (Ach)(postoperative 5 days)
  • Norepinephrine (NE)(postoperative 5 days)
  • The time of the first postoperative defecation and flatus expulsion(postoperative 3 days)
  • Platelet/lymphocyte ratio (PLR)(postoperative 5 days)
  • Visual analogue scale (VAS) Score(postoperative 5 days)
  • miR-10b-5p(postoperative 5 days)
  • Interleukin-10 (IL-10)(postoperative 5 days)
  • Quality-of-recovery 15 (Qor-15) Score(postoperative 5 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yang Bin

Principal Investigator

The First Affiliated Hospital of Xiamen University

研究点 (1)

Loading locations...

相似试验